Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.
Ohki K, Butler ER, Kiyokawa N, Hirabayashi S, Bergmann AK, Möricke A, Boer JM, Cavé H, Cazzaniga G, Yeoh AEJ, Sanada M, Imamura T, Inaba H, Mullighan CG, Loh ML, Norén-Nyström U, Shih LY, Zaliova M, Pui CH, Haas OA, Harrison CJ, Moorman AV, Manabe A.
Ohki K, et al. Among authors: inaba h.
Leukemia. 2023 Jan;37(1):212-216. doi: 10.1038/s41375-022-01737-4. Epub 2022 Oct 29.
Leukemia. 2023.
PMID: 36309560
Free PMC article.
No abstract available.